Tag: health care industry

February 5, 2026

Lilly Outpaces Novo Nordisk in Obesity Drug Market: 2026 Outlook

February 4, 2026

Eli Lilly Blows Past Estimates as Zepbound & Mounjaro Demand Soars

January 17, 2026

Novo Nordisk Shares Rise: Wegovy Obesity Pill Launch Success

January 16, 2026

Trump Health Care Plan Congress ACA Subsidies

January 10, 2026

Obesity Pills 2026: Novo Nordisk & Eli Lilly Lead the Way

January 9, 2026

Abivax Stock Surge: Biotech Takeover Target

January 1, 2026

UnitedHealth Group Audit Results Released

December 30, 2025

Trump’s 2025 Wall Street Deals: Tariffs & Uncertainty Slow M&A

December 27, 2025

Novo Nordisk’s GLP-1 Pill Approved by FDA for Obesity

December 18, 2025

Eli Lilly Obesity Pill Keeps Weight Loss After Wegovy, Zepbound

December 12, 2025

Fibermaxxing Trend: Food Brands Launch High-Fiber Products

December 11, 2025

Retatrutide: Eli Lilly Weight Loss Drug Shows Promise in Late-Stage Trial

December 9, 2025

Eli Lilly Alabama Plant: $6 Billion Manufacturing Expansion

December 8, 2025

RFK Jr.’s Panel Weakens FDA Guidance

December 4, 2025

RFK Jr.’s Vaccine Panel Hepatitis B Baby Shot Vote

December 1, 2025

Eli Lilly Cuts Cash Prices of Zepbound Weight Loss Drug Vials